Table 2 Analysis of the ADAPT trial
Outcome | Analysis | TE | SE (bootstrap SE) | 95% CI | P-value |
|---|---|---|---|---|---|
Total SCORAD | Unadjusted | −7.86 | 3.75 (3.70) | −15.36 to − 0.36 | 0.040 |
Adjusted - Regression | − 8.34 | 3.59 (3.62) | −15.53 to − 1.14 | 0.024 | |
Adjusted - IPTW | −8.27 | 3.43 (3.63) | −15.00 to − 1.54 | 0.016 | |
EASI | Unadjusted | −5.62 | 3.36 (3.32) | −12.34 to 1.10 | 0.099 |
Adjusted - Regression | −6.67 | 3.26 (3.29) | −13.21 to −0.13 | 0.046 | |
Adjusted - IPTW | −6.60 | 3.11 (3.26) | −12.69 to −0.50 | 0.034 | |
(C)DLQI | Unadjusted | −3.30 | 1.48 (1.47) | −6.26 to −0.34 | 0.030 |
Adjusted - Regression | −3.45 | 1.46 (1.47) | −6.38 to −0.53 | 0.022 | |
Adjusted - IPTW | −3.40 | 1.40 (1.49) | −6.15 to −0.65 | 0.015 |